CD8+T-cells are required for the therapeutic effects of glatiramer acetate (Copaxone) on autoimmune demyelination

被引：0
|
作者：
Mendoza, Jason [1 ]
York, Nathan [1 ]
Benagh, Andrew [1 ]
Firan, Mihail [1 ]
Karandikar, Nitin [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2008年 / 203卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：254 / 255
页数：2
相关论文
共 50 条
  • [1] CD8+T-cells are required for the therapeutic effects of glatiramer acetate (Copaxone) on autoimmune demyelination
    Mendoza, Jason P.
    York, Nathan R.
    Benagh, Andrew
    Karandikar, Nitin J.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [2] CD8+T cells are required for the therapeutic effects of glatiramer acetate (Copaxone) on autoimmune demyelination
    Mendoza, Jason
    York, Nathan
    Benagh, Andrew
    Firan, Mihail
    Karandikar, Nitin
    CLINICAL IMMUNOLOGY, 2008, 127 : S33 - S34
  • [3] CD8+T-cells are required for the action of glatiramer acetate therapy for autoimmune demyelinating disease
    Tyler, Andrew
    Mendoza, Jason
    Ortega, Sterling
    Firan, Mihail
    Karandikar, Nitin
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [4] Glatiramer acetate (Copaxone) therapy restores regulatory, cytotoxic CD8+T-cells in multiple sclerosis.
    Tennakoon, Deepani
    Mehta, Riyaz
    Ortega, Sterling
    Racke, Michael
    Karandikar, Nitin
    CLINICAL IMMUNOLOGY, 2006, 119 : S110 - S111
  • [5] Treatment of autoimmune demyelination by autoregulatory CD8+T-cells
    Ortega, Sterling
    Tyler, Andrew
    Kashi, Venkatesh
    Mendoza, Jason
    Benagh, Andrew
    Karandikar, Nitin
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [6] CD8+ T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease
    Tyler, Andrew F.
    Mendoza, Jason P.
    Firan, Mihail
    Karandikar, Nitin J.
    PLOS ONE, 2013, 8 (06):
  • [7] Potential regulatory role for CNS-specific, autoreactive CD8+T-cells in autoimmune demyelination
    York, Nathan Ronald
    Mendoza, Jason P.
    Benagh, Andrew
    Karandikar, Nitin J.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [8] CD4+CD25+ regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis
    Jee, Y.
    Piao, W. H.
    Liu, R.
    Bai, X. F.
    Rhodes, S.
    Rodebaugh, R.
    Campagnolo, D. I.
    Shi, F. D.
    Vollmer, T. L.
    CLINICAL IMMUNOLOGY, 2007, 125 (01) : 34 - 42
  • [9] CD4+CD25+ regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis
    Jee, Y.
    Piao, W.
    Liu, R.
    Bai, X. F.
    Price, M.
    Rhodes, S.
    Rodebaugh, R.
    Campagnolo, D.
    Shi, F. D.
    Vollmer, T.
    MULTIPLE SCLEROSIS, 2006, 12 : S56 - S57
  • [10] Glatiramer acetate (Copaxone) therapy induces CD8+ T cell responses in patients with multiple sclerosis
    Karandikar, NJ
    Crawford, MP
    Yan, X
    Ratts, RB
    Brenchley, JM
    Ambrozak, DR
    Lovett-Racke, AE
    Frohman, EM
    Stastny, P
    Douek, DC
    Koup, DA
    Racke, MK
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (05): : 641 - 649
12345